487000000491000000340000002810000002000000400000070000000020000007000000false--12-31Q22020000115603919021000000213580000000.010.0190000000090000000025292216125212236325292216125212236302500000005071000000170000000238000000230000000000100000020000004000000500000073000000174000000241000000300000000010000002000000001000000001000000000000 0001156039 2020-01-01 2020-06-30 0001156039 2020-07-22 0001156039 2020-06-30 0001156039 2019-12-31 0001156039 2020-04-01 2020-06-30 0001156039 2019-01-01 2019-06-30 0001156039 2019-04-01 2019-06-30 0001156039 2018-12-31 0001156039 2019-06-30 0001156039 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001156039 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001156039 us-gaap:CommonStockMember 2019-12-31 0001156039 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001156039 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001156039 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001156039 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001156039 2020-01-01 2020-03-31 0001156039 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001156039 us-gaap:RetainedEarningsMember 2020-03-31 0001156039 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001156039 2020-03-31 0001156039 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001156039 us-gaap:RetainedEarningsMember 2019-12-31 0001156039 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001156039 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001156039 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001156039 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001156039 us-gaap:CommonStockMember 2020-03-31 0001156039 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001156039 us-gaap:CommonStockMember 2020-06-30 0001156039 us-gaap:RetainedEarningsMember 2020-06-30 0001156039 2019-01-01 2019-03-31 0001156039 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001156039 us-gaap:RetainedEarningsMember 2018-12-31 0001156039 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001156039 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001156039 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001156039 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001156039 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001156039 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001156039 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001156039 us-gaap:CommonStockMember 2019-03-31 0001156039 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001156039 us-gaap:CommonStockMember 2018-12-31 0001156039 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001156039 2019-03-31 0001156039 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001156039 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001156039 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001156039 us-gaap:CommonStockMember 2019-06-30 0001156039 us-gaap:RetainedEarningsMember 2019-03-31 0001156039 us-gaap:RetainedEarningsMember 2019-06-30 0001156039 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001156039 2020-01-01 0001156039 srt:MinimumMember antm:BeaconHealthOptionsMember us-gaap:FiniteLivedIntangibleAssetsMember us-gaap:AllOtherSegmentsMember 2020-01-01 2020-06-30 0001156039 antm:BeaconHealthOptionsMember us-gaap:AllOtherSegmentsMember 2020-06-30 0001156039 srt:MaximumMember antm:BeaconHealthOptionsMember us-gaap:FiniteLivedIntangibleAssetsMember us-gaap:AllOtherSegmentsMember 2020-01-01 2020-06-30 0001156039 antm:BeaconHealthOptionsMember 2020-06-30 0001156039 us-gaap:ForeignGovernmentDebtMember 2020-01-01 2020-06-30 0001156039 us-gaap:CorporateDebtSecuritiesMember 2020-01-01 2020-06-30 0001156039 us-gaap:CorporateDebtSecuritiesMember 2020-06-30 0001156039 us-gaap:ForeignGovernmentDebtMember 2019-12-31 0001156039 us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001156039 us-gaap:ForeignGovernmentDebtMember 2020-06-30 0001156039 2019-01-01 2019-12-31 0001156039 us-gaap:PrivateEquityFundsMember 2020-06-30 0001156039 antm:FixedMaturityMutualFundsMember 2020-06-30 0001156039 antm:CommonEquitySecuritiesMember 2020-06-30 0001156039 us-gaap:ExchangeTradedFundsMember 2019-12-31 0001156039 antm:CommonEquitySecuritiesMember 2019-12-31 0001156039 us-gaap:ExchangeTradedFundsMember 2020-06-30 0001156039 antm:FixedMaturityMutualFundsMember 2019-12-31 0001156039 us-gaap:PrivateEquityFundsMember 2019-12-31 0001156039 us-gaap:EquitySecuritiesMember 2020-04-01 2020-06-30 0001156039 us-gaap:EquitySecuritiesMember 2019-01-01 2019-06-30 0001156039 us-gaap:EquitySecuritiesMember 2020-01-01 2020-06-30 0001156039 us-gaap:EquitySecuritiesMember 2019-04-01 2019-06-30 0001156039 us-gaap:CorporateDebtSecuritiesMember 2020-03-31 0001156039 us-gaap:CorporateDebtSecuritiesMember 2020-04-01 2020-06-30 0001156039 us-gaap:ForeignGovernmentDebtMember 2020-04-01 2020-06-30 0001156039 us-gaap:ForeignGovernmentDebtMember 2020-03-31 0001156039 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:OtherAggregatedInvestmentsMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:CorporateDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:OtherAggregatedInvestmentsMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:CorporateDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:ForeignGovernmentDebtMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-01-01 2019-12-31 0001156039 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2020-01-01 2020-06-30 0001156039 us-gaap:CorporateDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-01-01 2019-12-31 0001156039 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2020-01-01 2020-06-30 0001156039 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-01-01 2019-12-31 0001156039 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FixedMaturitiesMember 2019-01-01 2019-12-31 0001156039 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2019-01-01 2019-12-31 0001156039 us-gaap:FixedMaturitiesMember 2020-01-01 2020-06-30 0001156039 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FixedMaturitiesMember 2020-01-01 2020-06-30 0001156039 us-gaap:OtherAggregatedInvestmentsMember us-gaap:FixedMaturitiesMember 2020-01-01 2020-06-30 0001156039 us-gaap:OtherAggregatedInvestmentsMember us-gaap:FixedMaturitiesMember 2019-01-01 2019-12-31 0001156039 us-gaap:ForeignGovernmentDebtMember us-gaap:FixedMaturitiesMember 2020-01-01 2020-06-30 0001156039 us-gaap:CorporateDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-01-01 2020-06-30 0001156039 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2019-01-01 2019-12-31 0001156039 us-gaap:FixedMaturitiesMember 2019-01-01 2019-12-31 0001156039 us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-01-01 2020-06-30 0001156039 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-01-01 2020-06-30 0001156039 us-gaap:MaturityOvernightMember us-gaap:CashMember 2020-06-30 0001156039 us-gaap:MaturityOvernightMember us-gaap:OtherAggregatedInvestmentsMember 2020-06-30 0001156039 us-gaap:MaturityOvernightMember 2020-06-30 0001156039 us-gaap:MaturityOvernightMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001156039 us-gaap:CashFlowHedgingMember 2019-12-31 0001156039 us-gaap:CashFlowHedgingMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:PrivateEquityFundsMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignGovernmentDebtMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member 2019-12-31 0001156039 us-gaap:DerivativeMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:ExchangeTradedFundsMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:DerivativeMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignGovernmentDebtMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeMember 2019-12-31 0001156039 antm:FixedMaturityMutualFundsMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:PrivateEquityFundsMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member antm:CommonEquitySecuritiesMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:OtherDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member antm:FixedMaturityMutualFundsMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:PrivateEquityFundsMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:PrivateEquityFundsMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member antm:FixedMaturityMutualFundsMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 antm:CommonEquitySecuritiesMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:PrivateEquityFundsMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:OtherDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:ExchangeTradedFundsMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:OtherDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignGovernmentDebtMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeMember 2019-12-31 0001156039 us-gaap:OtherDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:PrivateEquityFundsMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member antm:CommonEquitySecuritiesMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:ExchangeTradedFundsMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member 2019-12-31 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:ExchangeTradedFundsMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:OtherDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:PrivateEquityFundsMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:OtherDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:PrivateEquityFundsMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member antm:CommonEquitySecuritiesMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:ExchangeTradedFundsMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:ExchangeTradedFundsMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member antm:FixedMaturityMutualFundsMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member antm:FixedMaturityMutualFundsMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member antm:CommonEquitySecuritiesMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member antm:FixedMaturityMutualFundsMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 antm:FixedMaturityMutualFundsMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member antm:FixedMaturityMutualFundsMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:ExchangeTradedFundsMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel2Member antm:CommonEquitySecuritiesMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:OtherDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:FixedMaturitiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member antm:CommonEquitySecuritiesMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:OtherDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 antm:CommonEquitySecuritiesMember us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:FixedMaturitiesMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:ExchangeTradedFundsMember us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-01-01 2019-06-30 0001156039 us-gaap:EquitySecuritiesMember 2019-01-01 2019-06-30 0001156039 us-gaap:OtherDebtSecuritiesMember 2019-12-31 0001156039 us-gaap:EquitySecuritiesMember 2020-01-01 2020-06-30 0001156039 us-gaap:OtherDebtSecuritiesMember 2019-01-01 2019-06-30 0001156039 us-gaap:OtherDebtSecuritiesMember 2020-01-01 2020-06-30 0001156039 us-gaap:OtherDebtSecuritiesMember 2020-06-30 0001156039 us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-01-01 2020-06-30 0001156039 us-gaap:EquitySecuritiesMember 2018-12-31 0001156039 us-gaap:CorporateDebtSecuritiesMember 2019-06-30 0001156039 us-gaap:CorporateDebtSecuritiesMember 2019-01-01 2019-06-30 0001156039 us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001156039 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-06-30 0001156039 us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001156039 us-gaap:EquitySecuritiesMember 2019-06-30 0001156039 us-gaap:EquitySecuritiesMember 2019-12-31 0001156039 us-gaap:ResidentialMortgageBackedSecuritiesMember 2018-12-31 0001156039 us-gaap:OtherDebtSecuritiesMember 2018-12-31 0001156039 us-gaap:EquitySecuritiesMember 2020-06-30 0001156039 us-gaap:OtherDebtSecuritiesMember 2019-06-30 0001156039 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001156039 us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001156039 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001156039 us-gaap:FairValueMeasurementsNonrecurringMember 2020-06-30 0001156039 us-gaap:EquitySecuritiesMember 2020-04-01 2020-06-30 0001156039 us-gaap:OtherDebtSecuritiesMember 2019-04-01 2019-06-30 0001156039 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-03-31 0001156039 us-gaap:CorporateDebtSecuritiesMember 2019-04-01 2019-06-30 0001156039 us-gaap:EquitySecuritiesMember 2019-04-01 2019-06-30 0001156039 us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-04-01 2020-06-30 0001156039 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-04-01 2019-06-30 0001156039 us-gaap:OtherDebtSecuritiesMember 2020-04-01 2020-06-30 0001156039 us-gaap:EquitySecuritiesMember 2019-03-31 0001156039 us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-03-31 0001156039 us-gaap:OtherDebtSecuritiesMember 2019-03-31 0001156039 us-gaap:OtherDebtSecuritiesMember 2020-03-31 0001156039 us-gaap:EquitySecuritiesMember 2020-03-31 0001156039 us-gaap:CorporateDebtSecuritiesMember 2019-03-31 0001156039 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-06-30 0001156039 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-06-30 0001156039 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-06-30 0001156039 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-06-30 0001156039 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-04-01 2020-06-30 0001156039 us-gaap:PensionPlansDefinedBenefitMember 2019-04-01 2019-06-30 0001156039 us-gaap:PensionPlansDefinedBenefitMember 2020-04-01 2020-06-30 0001156039 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-04-01 2019-06-30 0001156039 antm:GovernmentBusinessSegmentMember 2019-01-01 2019-03-31 0001156039 antm:CommercialSpecialtyBusinessSegmentMember 2019-01-01 2019-06-30 0001156039 antm:CommercialSpecialtyBusinessSegmentMember 2019-04-01 2019-06-30 0001156039 antm:CommercialSpecialtyBusinessSegmentMember 2019-01-01 2019-03-31 0001156039 antm:GovernmentBusinessSegmentMember 2019-01-01 2019-06-30 0001156039 antm:GovernmentBusinessSegmentMember 2019-04-01 2019-06-30 0001156039 antm:CommercialSpecialtyBusinessSegmentMember 2020-01-01 2020-06-30 0001156039 antm:OtherSegmentMember 2020-04-01 2020-06-30 0001156039 antm:GovernmentBusinessSegmentMember 2020-01-01 2020-03-31 0001156039 antm:OtherSegmentMember 2020-01-01 2020-03-31 0001156039 antm:CommercialSpecialtyBusinessSegmentMember 2020-01-01 2020-03-31 0001156039 antm:GovernmentBusinessSegmentMember 2020-01-01 2020-06-30 0001156039 antm:CommercialSpecialtyBusinessSegmentMember 2020-04-01 2020-06-30 0001156039 antm:OtherSegmentMember 2020-01-01 2020-06-30 0001156039 antm:GovernmentBusinessSegmentMember 2020-04-01 2020-06-30 0001156039 antm:ShortdurationInsuranceContractAccidentYear2020Member antm:CommercialSpecialtyBusinessSegmentMember 2020-06-30 0001156039 antm:ShortdurationInsuranceContractAccidentYear2020Member antm:GovernmentBusinessSegmentMember 2020-06-30 0001156039 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member antm:CommercialSpecialtyBusinessSegmentMember 2020-06-30 0001156039 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member antm:GovernmentBusinessSegmentMember 2020-06-30 0001156039 us-gaap:ShortDurationInsuranceContractAccidentYear2019Member antm:CommercialSpecialtyBusinessSegmentMember 2020-06-30 0001156039 us-gaap:ShortDurationInsuranceContractAccidentYear2019Member antm:OtherSegmentMember 2020-06-30 0001156039 us-gaap:ShortDurationInsuranceContractAccidentYear2019Member antm:GovernmentBusinessSegmentMember 2020-06-30 0001156039 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member antm:OtherSegmentMember 2020-06-30 0001156039 antm:ShortdurationInsuranceContractAccidentYear2020Member antm:OtherSegmentMember 2020-06-30 0001156039 antm:OtherSegmentMember 2020-06-30 0001156039 antm:CommercialSpecialtyBusinessSegmentMember 2020-06-30 0001156039 antm:GovernmentBusinessSegmentMember 2020-06-30 0001156039 antm:CommercialSpecialtyBusinessSegmentMember 2019-06-30 0001156039 antm:OtherSegmentMember 2019-01-01 2019-06-30 0001156039 antm:GovernmentBusinessSegmentMember 2019-06-30 0001156039 antm:OtherSegmentMember 2019-06-30 0001156039 antm:OtherSegmentMember 2018-12-31 0001156039 antm:GovernmentBusinessSegmentMember 2018-12-31 0001156039 antm:CommercialSpecialtyBusinessSegmentMember 2018-12-31 0001156039 antm:CommercialSpecialtyBusinessSegmentMember 2019-12-31 0001156039 antm:OtherSegmentMember 2019-12-31 0001156039 antm:GovernmentBusinessSegmentMember 2019-12-31 0001156039 us-gaap:FederalHomeLoanBankAdvancesMember 2020-06-30 0001156039 antm:SeniorUnsecuredNotesMember 2019-12-31 0001156039 us-gaap:RevolvingCreditFacilityMember 2020-01-01 2020-06-30 0001156039 us-gaap:ConvertibleDebtMember 2020-04-01 2020-06-30 0001156039 us-gaap:ConvertibleDebtMember 2020-01-01 2020-06-30 0001156039 us-gaap:CommercialPaperMember 2020-06-30 0001156039 us-gaap:FederalHomeLoanBankAdvancesMember 2019-12-31 0001156039 antm:TwoPointThreeSevenFiveDueTwoThousandTwentyFiveMember antm:SeniorUnsecuredNotesMember 2019-09-09 0001156039 antm:A5YearFacilityMember us-gaap:RevolvingCreditFacilityMember 2020-06-30 0001156039 us-gaap:CommercialPaperMember 2019-12-31 0001156039 antm:ThreePointOneTwoFiveDueTwoThousandFiftyMember antm:SeniorUnsecuredNotesMember 2020-05-05 0001156039 antm:TwoPointTwoFiveZeroDueTwoThousandThirtyMember antm:SeniorUnsecuredNotesMember 2020-05-05 0001156039 antm:TwoPointThreeSevenFiveDueTwoThousandTwentyFiveMember antm:SeniorUnsecuredNotesMember 2020-05-05 0001156039 antm:SeniorUnsecuredNotesMember 2020-06-30 0001156039 antm:SurplusNotesMember 2020-06-30 0001156039 antm:A364DayFacilityMember us-gaap:RevolvingCreditFacilityMember 2020-06-30 0001156039 us-gaap:LineOfCreditMember 2019-12-31 0001156039 us-gaap:LineOfCreditMember 2020-06-30 0001156039 us-gaap:ConvertibleDebtMember 2020-06-30 0001156039 antm:SurplusNotesMember 2019-12-31 0001156039 antm:A5YearFacilityMember us-gaap:RevolvingCreditFacilityMember 2019-12-31 0001156039 antm:AnthemInc.v.ExpressScriptsInc.Member antm:OperationalMember 2020-01-01 2020-06-30 0001156039 srt:MaximumMember 2020-06-30 0001156039 antm:AnthemInc.v.ExpressScriptsInc.Member antm:PharmacypricingMember 2020-01-01 2020-06-30 0001156039 antm:AnthemInc.v.ExpressScriptsInc.Member 2020-01-01 2020-06-30 0001156039 srt:MinimumMember 2020-06-30 0001156039 antm:BCBSAntitrustLitigationMember 2020-06-30 0001156039 us-gaap:SubsequentEventMember 2020-09-25 2020-09-25 0001156039 us-gaap:SubsequentEventMember 2020-07-28 0001156039 2017-12-07 0001156039 antm:A2017to2019Member us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-06-30 0001156039 antm:A2020to2022Member us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-06-30 0001156039 antm:ManagedCareProductsMember antm:CommercialSpecialtyBusinessSegmentMember 2019-01-01 2019-06-30 0001156039 antm:OtherProductsMember antm:CommercialSpecialtyBusinessSegmentMember 2020-04-01 2020-06-30 0001156039 antm:DentalVisionProductsAndServicesMember antm:CommercialSpecialtyBusinessSegmentMember 2020-04-01 2020-06-30 0001156039 antm:ManagedCareServicesMember antm:CommercialSpecialtyBusinessSegmentMember 2020-04-01 2020-06-30 0001156039 antm:SegmentEliminationsMember 2019-04-01 2019-06-30 0001156039 antm:PharmacyproductsandservicesMember antm:IngenioRxSegmentMember 2019-04-01 2019-06-30 0001156039 antm:SegmentEliminationsMember 2020-01-01 2020-06-30 0001156039 antm:SegmentEliminationsMember 2020-04-01 2020-06-30 0001156039 antm:PharmacyproductsandservicesMember antm:IngenioRxSegmentMember 2020-04-01 2020-06-30 0001156039 antm:OtherProductsMember antm:CommercialSpecialtyBusinessSegmentMember 2019-01-01 2019-06-30 0001156039 antm:DentalVisionProductsAndServicesMember antm:CommercialSpecialtyBusinessSegmentMember 2020-01-01 2020-06-30 0001156039 antm:ManagedCareProductsMember antm:GovernmentBusinessSegmentMember 2019-01-01 2019-06-30 0001156039 antm:IngenioRxSegmentMember 2020-01-01 2020-06-30 0001156039 antm:ManagedCareServicesMember antm:CommercialSpecialtyBusinessSegmentMember 2020-01-01 2020-06-30 0001156039 antm:ManagedCareServicesMember antm:GovernmentBusinessSegmentMember 2019-01-01 2019-06-30 0001156039 antm:ManagedCareProductsMember antm:CommercialSpecialtyBusinessSegmentMember 2020-01-01 2020-06-30 0001156039 antm:SegmentEliminationsMember 2019-01-01 2019-06-30 0001156039 antm:DentalVisionProductsAndServicesMember antm:CommercialSpecialtyBusinessSegmentMember 2019-04-01 2019-06-30 0001156039 antm:ManagedCareProductsMember antm:GovernmentBusinessSegmentMember 2020-01-01 2020-06-30 0001156039 antm:ManagedCareProductsMember antm:CommercialSpecialtyBusinessSegmentMember 2020-04-01 2020-06-30 0001156039 antm:OtherProductsMember antm:CommercialSpecialtyBusinessSegmentMember 2020-01-01 2020-06-30 0001156039 antm:OtherProductsMember antm:CommercialSpecialtyBusinessSegmentMember 2019-04-01 2019-06-30 0001156039 antm:ManagedCareServicesMember antm:CommercialSpecialtyBusinessSegmentMember 2019-04-01 2019-06-30 0001156039 antm:PharmacyproductsandservicesMember antm:IngenioRxSegmentMember 2019-01-01 2019-06-30 0001156039 antm:ManagedCareServicesMember antm:GovernmentBusinessSegmentMember 2020-04-01 2020-06-30 0001156039 antm:ManagedCareProductsMember antm:CommercialSpecialtyBusinessSegmentMember 2019-04-01 2019-06-30 0001156039 antm:ManagedCareProductsMember antm:GovernmentBusinessSegmentMember 2019-04-01 2019-06-30 0001156039 antm:PharmacyproductsandservicesMember antm:IngenioRxSegmentMember 2020-01-01 2020-06-30 0001156039 antm:IngenioRxSegmentMember 2020-04-01 2020-06-30 0001156039 antm:ManagedCareServicesMember antm:GovernmentBusinessSegmentMember 2020-01-01 2020-06-30 0001156039 antm:IngenioRxSegmentMember 2019-01-01 2019-06-30 0001156039 antm:ManagedCareServicesMember antm:CommercialSpecialtyBusinessSegmentMember 2019-01-01 2019-06-30 0001156039 antm:ManagedCareServicesMember antm:GovernmentBusinessSegmentMember 2019-04-01 2019-06-30 0001156039 antm:OtherSegmentMember 2019-04-01 2019-06-30 0001156039 antm:IngenioRxSegmentMember 2019-04-01 2019-06-30 0001156039 antm:DentalVisionProductsAndServicesMember antm:CommercialSpecialtyBusinessSegmentMember 2019-01-01 2019-06-30 0001156039 antm:ManagedCareProductsMember antm:GovernmentBusinessSegmentMember 2020-04-01 2020-06-30 0001156039 antm:CommercialSpecialtyMember antm:AffiliatedMember 2019-01-01 2019-06-30 0001156039 antm:OtherSegmentMember 2019-04-01 2019-06-30 0001156039 antm:OtherSegmentMember antm:AffiliatedMember 2019-01-01 2019-06-30 0001156039 antm:CommercialSpecialtyMember 2019-01-01 2019-06-30 0001156039 us-gaap:IntersegmentEliminationMember 2019-04-01 2019-06-30 0001156039 us-gaap:IntersegmentEliminationMember 2020-04-01 2020-06-30 0001156039 antm:OtherSegmentMember 2020-01-01 2020-06-30 0001156039 antm:GovernmentBusinessSegmentMember antm:AffiliatedMember 2019-01-01 2019-06-30 0001156039 antm:UnaffiliatedMember antm:CommercialSpecialtyMember 2019-01-01 2019-06-30 0001156039 antm:OtherSegmentMember antm:AffiliatedMember 2020-01-01 2020-06-30 0001156039 antm:OtherSegmentMember 2019-01-01 2019-06-30 0001156039 antm:IngenioRxSegmentMember 2020-01-01 2020-06-30 0001156039 antm:UnaffiliatedMember antm:OtherSegmentMember 2020-04-01 2020-06-30 0001156039 antm:GovernmentBusinessSegmentMember 2019-04-01 2019-06-30 0001156039 antm:UnaffiliatedMember antm:OtherSegmentMember 2019-01-01 2019-06-30 0001156039 antm:CommercialSpecialtyMember 2020-01-01 2020-06-30 0001156039 antm:UnaffiliatedMember antm:IngenioRxSegmentMember 2019-04-01 2019-06-30 0001156039 antm:UnaffiliatedMember 2019-04-01 2019-06-30 0001156039 antm:CommercialSpecialtyMember antm:AffiliatedMember 2020-01-01 2020-06-30 0001156039 antm:UnaffiliatedMember 2020-04-01 2020-06-30 0001156039 antm:IngenioRxSegmentMember antm:AffiliatedMember 2020-01-01 2020-06-30 0001156039 antm:UnaffiliatedMember 2019-01-01 2019-06-30 0001156039 antm:OtherSegmentMember 2020-04-01 2020-06-30 0001156039 antm:IngenioRxSegmentMember antm:AffiliatedMember 2019-01-01 2019-06-30 0001156039 antm:GovernmentBusinessSegmentMember 2020-01-01 2020-06-30 0001156039 antm:UnaffiliatedMember antm:OtherSegmentMember 2020-01-01 2020-06-30 0001156039 antm:CommercialSpecialtyMember 2020-04-01 2020-06-30 0001156039 antm:UnaffiliatedMember antm:IngenioRxSegmentMember 2019-01-01 2019-06-30 0001156039 antm:UnaffiliatedMember antm:CommercialSpecialtyMember 2020-01-01 2020-06-30 0001156039 antm:IngenioRxSegmentMember 2019-04-01 2019-06-30 0001156039 antm:AffiliatedMember 2020-01-01 2020-06-30 0001156039 antm:AffiliatedMember 2019-04-01 2019-06-30 0001156039 antm:UnaffiliatedMember antm:GovernmentBusinessSegmentMember 2019-04-01 2019-06-30 0001156039 antm:GovernmentBusinessSegmentMember 2019-01-01 2019-06-30 0001156039 antm:AffiliatedMember 2019-01-01 2019-06-30 0001156039 antm:GovernmentBusinessSegmentMember antm:AffiliatedMember 2019-04-01 2019-06-30 0001156039 antm:IngenioRxSegmentMember antm:AffiliatedMember 2019-04-01 2019-06-30 0001156039 us-gaap:IntersegmentEliminationMember 2020-01-01 2020-06-30 0001156039 antm:CommercialSpecialtyMember 2019-04-01 2019-06-30 0001156039 antm:UnaffiliatedMember 2020-01-01 2020-06-30 0001156039 antm:GovernmentBusinessSegmentMember 2020-04-01 2020-06-30 0001156039 antm:UnaffiliatedMember antm:GovernmentBusinessSegmentMember 2019-01-01 2019-06-30 0001156039 antm:AffiliatedMember 2020-04-01 2020-06-30 0001156039 antm:UnaffiliatedMember antm:IngenioRxSegmentMember 2020-01-01 2020-06-30 0001156039 antm:UnaffiliatedMember antm:GovernmentBusinessSegmentMember 2020-04-01 2020-06-30 0001156039 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-06-30 0001156039 antm:IngenioRxSegmentMember 2020-04-01 2020-06-30 0001156039 antm:IngenioRxSegmentMember antm:AffiliatedMember 2020-04-01 2020-06-30 0001156039 antm:GovernmentBusinessSegmentMember antm:AffiliatedMember 2020-01-01 2020-06-30 0001156039 antm:CommercialSpecialtyMember antm:AffiliatedMember 2019-04-01 2019-06-30 0001156039 antm:UnaffiliatedMember antm:GovernmentBusinessSegmentMember 2020-01-01 2020-06-30 0001156039 antm:UnaffiliatedMember antm:OtherSegmentMember 2019-04-01 2019-06-30 0001156039 antm:IngenioRxSegmentMember 2019-01-01 2019-06-30 0001156039 antm:UnaffiliatedMember antm:IngenioRxSegmentMember 2020-04-01 2020-06-30 0001156039 antm:UnaffiliatedMember antm:CommercialSpecialtyMember 2019-04-01 2019-06-30 0001156039 antm:OtherSegmentMember antm:AffiliatedMember 2020-04-01 2020-06-30 0001156039 antm:UnaffiliatedMember antm:CommercialSpecialtyMember 2020-04-01 2020-06-30 0001156039 antm:OtherSegmentMember antm:AffiliatedMember 2019-04-01 2019-06-30 0001156039 us-gaap:OtherNoncurrentAssetsMember 2019-12-31 0001156039 us-gaap:OtherCurrentLiabilitiesMember 2019-12-31 0001156039 us-gaap:OtherNoncurrentLiabilitiesMember 2019-12-31 0001156039 us-gaap:OtherCurrentLiabilitiesMember 2020-06-30 0001156039 us-gaap:OtherNoncurrentLiabilitiesMember 2020-06-30 0001156039 us-gaap:OtherNoncurrentAssetsMember 2020-06-30 iso4217:USD xbrli:shares antm:securities antm:medical_member iso4217:USD antm:individual_member antm:county xbrli:shares xbrli:pure antm:states antm:segment
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended June 30, 2020
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                     
Commission file number: 001-16751
ANTHEM, INC.
(Exact name of registrant as specified in its charter)
Indiana
 
35-2145715
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification Number)
220 Virginia Avenue
Indianapolis, Indiana 46204
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (800331-1476
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading symbol(s)
 
Name of each exchange on which registered
Common Stock, $0.01 par value
 
ANTM
 
New York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒ No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large accelerated filer

 
  
Accelerated filer
Non-accelerated filer

 
  
Smaller reporting company
Emerging growth company
 
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  ☒
As of July 22, 2020, 251,506,458 shares of the Registrant’s Common Stock were outstanding.



Anthem, Inc.
Quarterly Report on Form 10-Q
For the Period Ended June 30, 2020
Table of Contents
 
 
 
Page
PART I. FINANCIAL INFORMATION
 
 
 
 
ITEM 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 2.
ITEM 3.
ITEM 4.
PART II. OTHER INFORMATION
 
ITEM 1.
ITEM 1A.
ITEM 2.
ITEM 3.
ITEM 4.
ITEM 5.
ITEM 6.

-1-



PART I. FINANCIAL INFORMATION
ITEM 1.
FINANCIAL STATEMENTS
Anthem, Inc.
Consolidated Balance Sheets
 
June 30,
2020
 
December 31,
2019
(In millions, except share data)
(Unaudited)
 
 
Assets
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
6,028

 
$
4,937

Fixed maturity securities (amortized cost of $21,358 and $19,021; allowance for credit losses of $24 and $0)
22,018

 
19,676

Equity securities
3,470

 
1,009

Premium receivables
5,456

 
5,014

Self-funded receivables
2,460

 
2,570

Other receivables
3,072

 
2,807

Other current assets
4,260

 
3,020

Total current assets
46,764

 
39,033

Long-term investments:
 
 
 
Fixed maturity securities (amortized cost of $491 and $487;
allowance for credit losses of $0 and $0)
520

 
505

Other invested assets
4,097

 
4,258

Property and equipment, net
3,427

 
3,133

Goodwill
21,641

 
20,500

Other intangible assets
9,577

 
8,674

Other noncurrent assets
1,950

 
1,350

Total assets
$
87,976

 
$
77,453

 
 
 
 
Liabilities and shareholders’ equity
 
 
 
Liabilities
 
 
 
Current liabilities:
 
 
 
Medical claims payable
$
9,878

 
$
8,842

Other policyholder liabilities
3,586

 
3,050

Unearned income
946

 
1,017

Accounts payable and accrued expenses
5,257

 
4,198

Short-term borrowings

 
700

Current portion of long-term debt
1,603

 
1,598

Other current liabilities
7,252

 
4,127

Total current liabilities
28,522

 
23,532

Long-term debt, less current portion
19,873

 
17,787

Reserves for future policy benefits
776

 
759

Deferred tax liabilities, net
2,497

 
2,227

Other noncurrent liabilities
1,853

 
1,420

Total liabilities
53,521

 
45,725

Commitments and contingencies – Note 11


 


Shareholders’ equity
 
 
 
Preferred stock, without par value, shares authorized – 100,000,000; shares issued and outstanding – none

 

Common stock, par value $0.01, shares authorized – 900,000,000; shares issued and outstanding –
252,122,363 and 252,922,161
3

 
3

Additional paid-in capital
9,360

 
9,448

Retained earnings
25,346

 
22,573

Accumulated other comprehensive loss
(254
)
 
(296
)
Total shareholders’ equity
34,455

 
31,728

Total liabilities and shareholders’ equity
$
87,976

 
$
77,453








See accompanying notes.

-2-



Anthem, Inc.
Consolidated Statements of Income
(Unaudited) 
 
Three Months Ended 
 June 30
 
Six Months Ended 
 June 30
(In millions, except per share data)
2020
 
2019
 
2020
 
2019
Revenues
 
 
 
 
 
 
 
Premiums
$
25,092

 
$
23,501

 
$
50,609

 
$
46,344

Product revenue
2,543

 
144

 
4,887

 
144

Administrative fees and other revenue
1,543

 
1,532

 
3,130

 
3,077

Total operating revenue
29,178

 
25,177

 
58,626

 
49,565

Net investment income
57

 
285

 
311

 
495

Net realized gains (losses) on financial instruments
18

 
11

 
(6
)
 
89

Impairment recoveries (losses) on investments:
 
 
 
 
 
 
 
Total impairment recoveries (losses) on investments
6

 
(9
)
 
(95
)
 
(22
)
Portion of impairment losses recognized in other comprehensive income
5

 
2

 
49

 
5

Impairment recoveries (losses) recognized in income
11

 
(7
)
 
(46
)
 
(17
)
Total revenues
29,264

 
25,466

 
58,885

 
50,132

Expenses
 
 
 
 
 
 
 
Benefit expense
19,547

 
20,368

 
41,036

 
39,650

Cost of products sold
2,225

 
98

 
4,209

 
98

Selling, general and administrative expense
4,046

 
3,278

 
7,827

 
6,444

Interest expense
201

 
184

 
395

 
371

Amortization of other intangible assets
93

 
85

 
176

 
172

Loss (gain) on extinguishment of debt
3

 

 
4

 
(1
)
Total expenses
26,115

 
24,013

 
53,647

 
46,734

Income before income tax expense
3,149

 
1,453

 
5,238

 
3,398

Income tax expense
873

 
314

 
1,439

 
708

Net income
$
2,276

 
$
1,139

 
$
3,799

 
$
2,690

Net income per share
 
 
 
 
 
 
 
Basic
$
9.02

 
$
4.44

 
$
15.06

 
$
10.47

Diluted
$
8.91

 
$
4.36

 
$
14.85

 
$
10.28

Dividends per share
$
0.95

 
$
0.80

 
$
1.90

 
$
1.60














See accompanying notes.

-3-



Anthem, Inc.
Consolidated Statements of Comprehensive Income
(Unaudited) 
 
 
Three Months Ended 
 June 30
 
Six Months Ended 
 June 30
(In millions)
 
2020
 
2019
 
2020
 
2019
Net income
 
$
2,276

 
$
1,139

 
$
3,799

 
$
2,690

Other comprehensive income, net of tax:
 
 
 
 
 
 
 
 
Change in net unrealized losses/gains on investments
 
730

 
238

 
41

 
595

Change in non-credit component of impairment losses on investments
 
10

 
(1
)
 
(22
)
 
(1
)
Change in net unrealized gains/losses on cash flow hedges
 
3

 

 
6

 
3

Change in net periodic pension and postretirement costs
 
10

 
3

 
17

 
6

Foreign currency translation adjustments
 
1

 

 

 

Other comprehensive income
 
754

 
240

 
42

 
603

Total comprehensive income
 
$
3,030

 
$
1,379

 
$
3,841

 
$
3,293


































See accompanying notes.

-4-


Anthem, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
 
Six Months Ended 
 June 30
(In millions)
2020
 
2019
Operating activities
 
 
 
Net income
$
3,799

 
$
2,690

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Net realized losses (gains) on financial instruments
6

 
(89
)
Depreciation and amortization
556

 
586

Deferred income taxes
60

 
79

Share-based compensation
134

 
140

Changes in operating assets and liabilities:
 
 
 
Receivables, net
(313
)
 
(589
)
Other invested assets
24

 
(28
)
Other assets
(486
)
 
(258
)
Policy liabilities
1,024

 
1,251

Unearned income
(110
)
 
(2
)
Accounts payable and other liabilities
1,868

 
(383
)
Income taxes
1,313

 
(286
)
Other, net
150

 
(44
)
Net cash provided by operating activities
8,025

 
3,067

Investing activities
 
 
 
Purchases of investments
(11,135
)
 
(11,113
)
Proceeds from sale of investments
4,724

 
8,835

Maturities, calls and redemptions from investments
1,836

 
894

Purchases of subsidiaries, net of cash acquired
(1,906
)
 

Purchases of property and equipment
(437
)
 
(455
)
Other, net
(800
)
 
22

Net cash used in investing activities
(7,718
)
 
(1,817
)
Financing activities
 
 
 
Net (repayments of) proceeds from commercial paper borrowings
(400
)
 
203

Proceeds from long-term borrowings
2,484

 

Repayments of long-term borrowings
(155
)
 
(73
)
Proceeds from short-term borrowings
820

 
4,805

Repayments of short-term borrowings
(1,520
)
 
(4,940
)
Repurchase and retirement of common stock
(584
)
 
(752
)
Cash dividends
(482
)
 
(412
)
Proceeds from issuance of common stock under employee stock plans
92

 
100

Taxes paid through withholding of common stock under employee stock plans
(111
)
 
(80
)
Other, net
640

 
43

Net cash provided by (used in) financing activities
784

 
(1,106
)
Change in cash and cash equivalents
1,091

 
144

Cash and cash equivalents at beginning of period
4,937

 
3,934

Cash and cash equivalents at end of period
$
6,028

 
$
4,078















See accompanying notes.

-5-


Anthem, Inc.
Consolidated Statements of Shareholders’ Equity
(Unaudited)
 
Six Months Ended June 30, 2020
 
Common Stock
 
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Loss
 
Total
Shareholders’
Equity
(In millions)
Number of
Shares
 
Par
Value
 
December 31, 2019 (audited)
252.9

 
$
3

 
$
9,448

 
$
22,573

 
$
(296
)
 
$
31,728

Adoption of Accounting Standards Update No. 2016-13 (Note 2)

 

 

 
(35
)
 

 
(35
)
January 1, 2020
252.9

 
3

 
9,448

 
22,538

 
(296
)
 
31,693

Net income

 

 

 
1,523

 

 
1,523

Other comprehensive loss

 

 

 

 
(712
)
 
(712
)
Repurchase and retirement of common stock
(1.9
)
 

 
(71
)
 
(458
)
 

 
(529
)
Dividends and dividend equivalents

 

 

 
(243
)
 

 
(243
)
Issuance of common stock under employee stock plans, net of related tax benefits
1.0

 

 
3

 

 

 
3

Convertible debenture repurchases and conversions

 

 
(42
)
 

 

 
(42
)
March 31, 2020
252.0

 
3

 
9,338

 
23,360

 
(1,008
)
 
31,693

Net income

 

 

 
2,276

 

 
2,276

Other comprehensive income

 

 

 

 
754

 
754

Repurchase and retirement of common stock
(0.2
)
 

 
(9
)
 
(46
)
 

 
(55
)
Dividends and dividend equivalents

 

 

 
(244
)
 

 
(244
)
Issuance of common stock under employee stock plans, net of related tax benefits
0.3

 

 
113

 

 

 
113

Convertible debenture repurchases and conversions

 

 
(82
)
 

 

 
(82
)
June 30, 2020
252.1

 
$
3

 
$
9,360

 
$
25,346

 
$
(254
)
 
$
34,455
















See accompanying notes.


-6-


Anthem, Inc.
Consolidated Statements of Shareholders’ Equity (continued)
(Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
 
Six Months Ended June 30, 2019
 
Common Stock
 
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Loss
 
Total
Shareholders’
Equity
(In millions)
Number of
Shares
 
Par
Value
 
December 31, 2018 (audited)
257.4

 
$
3

 
$
9,536

 
$
19,988

 
$
(986
)
 
$
28,541

Adoption of Accounting Standards Update No. 2016-02 (Note 2)

 

 

 
26

 

 
26

January 1, 2019
257.4

 
3

 
9,536

 
20,014

 
(986
)
 
28,567

Net income

 

 

 
1,551

 

 
1,551

Other comprehensive income

 

 

 

 
363

 
363

Repurchase and retirement of common stock
(1.1
)
 

 
(71
)
 
(223
)
 

 
(294
)
Dividends and dividend equivalents

 

 

 
(206
)
 

 
(206
)
Issuance of common stock under employee stock plans, net of related tax benefits
1.1

 

 
69

 

 

 
69

Convertible debenture repurchases and conversions

 

 
(52
)
 

 

 
(52
)
March 31, 2019
257.4

 
3

 
9,482

 
21,136

 
(623
)
 
29,998

Net income

 

 

 
1,139

 

 
1,139

Other comprehensive income

 

 

 

 
240

 
240

Repurchase and retirement of common stock
(1.7
)
 

 
(70
)
 
(388
)
 

 
(458
)
Dividends and dividend equivalents

 

 

 
(208
)
 

 
(208
)
Issuance of common stock under employee stock plans, net of related tax benefits
0.2

 

 
91

 

 

 
91

Convertible debenture repurchases and conversions

 

 
(9
)
 

 

 
(9
)
June 30, 2019
255.9

 
$
3

 
$
9,494

 
$
21,679

 
$
(383
)
 
$
30,793















See accompanying notes.

-7-


Anthem, Inc.
Notes to Consolidated Financial Statements
(Unaudited)
June 30, 2020
(In Millions, Except Per Share Data or As Otherwise Stated Herein)
 
1.
Organization
References to the terms “we,” “our,” “us” or “Anthem” used throughout these Notes to Consolidated Financial Statements refer to Anthem, Inc., an Indiana corporation, and unless the context otherwise requires, its direct and indirect subsidiaries. References to the “states” include the District of Columbia, unless the context otherwise requires.
We are one of the largest health benefits companies in the United States in terms of medical membership, serving greater than 42 million medical members through our affiliated health plans as of June 30, 2020. We offer a broad spectrum of network-based managed care plans to Large Group, Small Group, Individual, Medicaid and Medicare markets. Our managed care plans include: Preferred Provider Organizations, or PPOs; Health Maintenance Organizations, or HMOs; Point-of-Service plans; traditional indemnity plans and other hybrid plans, including Consumer-Driven Health Plans; and hospital only and limited benefit products. In addition, we provide a broad array of managed care services to self-funded customers, including claims processing, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. We provide an array of specialty and other insurance products and services such as pharmacy benefits management, or PBM, dental, vision, life and disability insurance benefits, radiology benefit management and analytics-driven personal healthcare. We also provide services to the federal government in connection with our Federal Health Products & Services business, which administers the Federal Employees Health Benefits, or FEHB, Program.
We are an independent licensee of the Blue Cross and Blue Shield Association, or BCBSA, an association of independent health benefit plans. We serve our members as the Blue Cross licensee for California and as the Blue Cross and Blue Shield, or BCBS, licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (in the New York City metropolitan area and upstate New York), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.) and Wisconsin. In a majority of these service areas, we do business as Anthem Blue Cross, Anthem Blue Cross and Blue Shield, and Empire Blue Cross Blue Shield or Empire Blue Cross. We also conduct business through arrangements with other BCBS licensees as well as other strategic partners. Through our subsidiaries, we also serve customers in numerous states across the country as AIM Specialty Health, Amerigroup, Aspire Health, Beacon, CareMore, Freedom Health, HealthLink, HealthSun, Optimum HealthCare, Simply Healthcare, and/or Unicare. Also, in the second quarter of 2019, we began providing PBM services through our IngenioRx subsidiary. We are licensed to conduct insurance operations in all 50 states and the District of Columbia through our subsidiaries.
2.
Basis of Presentation and Significant Accounting Policies
Basis of Presentation: The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. We have omitted certain footnote disclosures that would substantially duplicate the disclosures in our 2019 Annual Report on Form 10-K, unless the information contained in those disclosures materially changed or is required by GAAP. Certain prior year amounts have been reclassified to conform to the current year presentation. For additional information on prior year reclassifications, see Note 15, “Segment Information.” In the opinion of management, all adjustments, including normal recurring adjustments, necessary for a fair statement of the consolidated financial statements as of and for the three and six months ended June 30, 2020 and 2019 have been recorded. The results of operations for the three and six months ended June 30, 2020 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2020, or any other period. These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements as of and for the year ended December 31, 2019 included in our 2019 Annual Report on Form 10-K.
Certain of our subsidiaries operate outside of the United States and have functional currencies other than the U.S. dollar, or USD. We translate the assets and liabilities of those subsidiaries to USD using the exchange rate in effect at the end of the

-8-



period. We translate the revenues and expenses of those subsidiaries to USD using the average exchange rates in effect during the period. The net effect of these translation adjustments is included in “Foreign currency translation adjustments” in our consolidated statements of comprehensive income.
Cash and Cash Equivalents: We control a number of bank accounts that are used exclusively to hold customer funds for the administration of customer benefits, and we have cash and cash equivalents on deposit to meet certain regulatory requirements. These amounts totaled $231 and $215 at June 30, 2020 and December 31, 2019, respectively, and are included in the cash and cash equivalents line on our consolidated balance sheets.
Investments: Prior to 2020, our fixed maturities were evaluated for other-than-temporary impairment where credit-related impairments were presented within the other-than-temporary impairment losses recognized in our consolidated statements of income with an adjustment to the security’s amortized cost basis. Effective January 1, 2020, if a fixed maturity security is in an unrealized loss position and we have the intent to sell the fixed maturity security, or it is more likely than not that we will have to sell the fixed maturity security before recovery of its amortized cost basis, we write down the fixed maturity security’s cost basis to fair value and record an impairment loss in our consolidated statements of income. For impaired fixed maturity securities that we do not intend to sell or if it is more likely than not that we will not have to sell such securities, but we expect that we will not fully recover the amortized cost basis, we recognize the credit component of the impairment as an allowance for credit loss in our consolidated balance sheets and record an impairment loss in our consolidated statements of income. The non-credit component of the impairment is recognized in accumulated other comprehensive loss. Furthermore, unrealized losses entirely caused by non-credit-related factors related to fixed maturity securities for which we expect to fully recover the amortized cost basis continue to be recognized in accumulated other comprehensive loss.
The credit component of an impairment is determined primarily by comparing the net present value of projected future cash flows with the amortized cost basis of the fixed maturity security. The net present value is calculated by discounting our best estimate of projected future cash flows at the effective interest rate implicit in the fixed maturity security at the date of purchase. For mortgage-backed and asset-backed securities, cash flow estimates are based on assumptions regarding the underlying collateral, including prepayment speeds, vintage, type of underlying asset, geographic concentrations, default rates, recoveries and changes in value. For all other securities, cash flow estimates are driven by assumptions regarding probability of default, including changes in credit ratings and estimates regarding timing and amount of recoveries associated with a default.
For asset-backed securities included in fixed maturity securities, we recognize income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The net investment in the securities is adjusted to the amount that would have existed had the new effective yield been applied since the purchase date of the securities. Such adjustments are reported within net investment income.
In accordance with the Financial Accounting Standards Board, or FASB, guidance, the changes in fair value of our marketable equity securities are recognized in our results of operations within net realized gains and losses on financial instruments.
We have corporate-owned life insurance policies on certain participants in our deferred compensation plans and other members of management. The cash surrender value of the corporate-owned life insurance policies is reported under the caption “Other invested assets” in our consolidated balance sheets.
We use the equity method of accounting for investments in companies in which our ownership interest may enable us to influence the operating or financial decisions of the investee company. Our proportionate share of equity in net income of these unconsolidated affiliates is reported within net investment income. The equity method investments are reported under the caption “Other invested assets” in our consolidated balance sheets.
Investment income is recorded when earned. All securities sold resulting in investment gains and losses are recorded on the trade date. Realized gains and losses are determined on the basis of the cost or amortized cost of the specific securities sold.

-9-



We participate in securities lending programs whereby marketable securities in our investment portfolio are transferred to independent brokers or dealers in exchange for cash and securities collateral. Under FASB guidance related to accounting for transfers and servicing of financial assets and extinguishments of liabilities, we recognize the collateral as an asset, which is reported under the caption “Other current assets” in our consolidated balance sheets, and we record a corresponding liability for the obligation to return the collateral to the borrower, which is reported under the caption “Other current liabilities” in our consolidated balance sheets. The securities on loan are reported in the applicable investment category on our consolidated balance sheets. Unrealized gains or losses on securities lending collateral are included in accumulated other comprehensive loss as a separate component of shareholders’ equity. The market value of loaned securities and that of the collateral pledged can fluctuate in non-synchronized fashions. To the extent the loaned securities’ value appreciates faster or depreciates slower than the value of the collateral pledged, we are exposed to the risk of the shortfall. As a primary mitigating mechanism, the loaned securities and collateral pledged are marked to market on a daily basis and the shortfall, if any, is collected accordingly. Secondarily, the collateral level is set at 102% of the value of the loaned securities, which provides a cushion before any shortfall arises. The investment of the cash collateral is subject to market risk, which is managed by limiting the investments to higher quality and shorter duration instruments.
Receivables: Premium receivables include the uncollected amounts from insured groups, individuals and government programs. Premium receivables are reported net of an allowance for doubtful accounts of $259 and $237 at June 30, 2020 and December 31, 2019, respectively. Self-funded receivables include administrative fees, claims and other amounts due from self-funded customers.
Self-funded receivables are reported net of an allowance for doubtful accounts of $52 and $46 at June 30, 2020 and December 31, 2019, respectively. The allowance for doubtful accounts is based on historical collection trends, future forecasts and our judgment regarding the ability to collect specific accounts.
Other receivables include pharmacy rebates, provider advances, claims recoveries, reinsurance receivables, proceeds due from brokers on investment trades, other government receivables and other miscellaneous amounts due to us. These receivables are reported net of an allowance for doubtful accounts of $321 and $242 at June 30, 2020 and December 31, 2019, respectively, which is based on historical collection trends, future forecasts and our judgment regarding the ability to collect specific accounts.
Revenue Recognition: For our non-fully-insured contracts, we had no material contract assets, contract liabilities or deferred contract costs recorded on our consolidated balance sheet at June 30, 2020. For the three and six months ended June 30, 2020, revenue recognized from performance obligations related to prior periods, such as due to changes in transaction price, was not material. For contracts that have an original expected duration of greater than one year, revenue expected to be recognized in future periods related to unfulfilled contractual performance obligations and contracts with variable consideration related to undelivered performance obligations is not material.
Recently Adopted Accounting Guidance: In November 2019, the FASB issued Accounting Standards Update No. 2019-11, Codification Improvements to Topic 326, Financial Instruments - Credit Losses. In May 2019, the FASB issued Accounting Standards Update No. 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief. In April 2019, the FASB issued Accounting Standards Update No. 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. In November 2018, the FASB issued Accounting Standards Update No. 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses. These updates provide an option to irrevocably elect to measure certain individual financial assets at fair value instead of amortized cost and provide additional clarification and implementation guidance on certain aspects of the previously issued Accounting Standards Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, or ASU 2016-13, and have the same effective date and transition requirements as ASU 2016-13. ASU 2016-13 introduces a current expected credit loss model for measuring expected credit losses for certain types of financial instruments held at the reporting date based on historical experience, current conditions and reasonable supportable forecasts. ASU 2016-13 replaces the current incurred loss model for measuring expected credit losses, requires expected losses on available-for-sale debt securities to be recognized through an allowance for credit losses rather than as reductions in the amortized cost of the securities and provides for additional disclosure requirements. ASU 2016-13 requires a cumulative-effect adjustment to the opening balance of retained earnings on the statement of financial position at the date of adoption and a prospective transition approach for debt securities for which an other-than-temporary impairment had been recognized before the adoption date. The effect of a prospective transition approach is to maintain the

-10-



same amortized cost basis before and after the date of adoption. We adopted ASU 2016-13 on January 1, 2020, and recognized a cumulative-effect adjustment of $35 to our opening retained earnings for credit related allowances on receivables. The adoption did not have an impact on our consolidated statements of income or cash flows.
In August 2018, the FASB issued Accounting Standards Update No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract, or ASU 2018-15. The amendments in ASU 2018-15 require implementation costs incurred by customers in cloud computing arrangements to be deferred and recognized over the term of the arrangement, if those costs would be capitalized by the customer in a software licensing arrangement under the internal-use software guidance. The amendments also require an entity to disclose the nature of its hosting arrangements and adhere to certain presentation requirements in its balance sheet, income statement and statement of cash flows. We adopted ASU 2018-15 on January 1, 2020 using a prospective approach for all implementation costs incurred after the date of adoption, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.
In August 2018, the FASB issued Accounting Standards Update No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement, or ASU 2018-13. The amendments in ASU 2018-13 eliminate, add, and modify certain disclosure requirements for fair value measurements. The amendments are effective for interim and annual periods beginning after December 15, 2019, with early adoption permitted for either the entirety of ASU 2018-13 or only the provisions that eliminate or modify disclosure requirements. We early adopted the provisions that eliminate and modify disclosure requirements, on a retrospective basis, effective in our 2018 Annual Report on Form 10-K. We adopted the new disclosure requirements on January 1, 2020, on a prospective basis.
In January 2017, the FASB issued Accounting Standards Update No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, or ASU 2017-04. This update removes Step 2 of the goodwill impairment test under current guidance, which required a hypothetical purchase price allocation. The new guidance requires an impairment charge to be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. We adopted ASU 2017-04 on January 1, 2020, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.
Recent Accounting Guidance Not Yet Adopted: In March 2020, the FASB issued Accounting Standards Update No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, or ASU 2020-04. ASU 2020-04 provides optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate, or LIBOR, or another reference rate expected to be discontinued because of the reference rate reform. The provisions must be applied at a Topic, Subtopic, or Industry Subtopic level for all transactions other than derivatives, which may be applied at a hedging relationship level. The provisions within ASU 2020-04 are available until December 31, 2022, when the reference rate replacement activity is expected to have been completed. We are currently evaluating the provisions within ASU 2020-04.
In December 2019, the FASB issued Accounting Standards Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, or ASU 2019-12. The amendments in ASU 2019-12 remove certain exceptions to the general principles in Accounting Standards Codification Topic 740. The amendments also clarify and amend existing guidance to improve consistent application. The amendments are effective for our annual reporting periods beginning after December 15, 2020, with early adoption permitted. The transition method (retrospective, modified retrospective, or prospective basis) related to the amendments depends on the applicable guidance, and all amendments for which there is no transition guidance specified are to be applied on a prospective basis. We are currently evaluating the effects the adoption of ASU 2019-12 will have on our consolidated financial statements.
In August 2018, the FASB issued Accounting Standards Update No. 2018-14, Compensation—Retirement Benefits - Defined Benefit Plans—General (Subtopic 715-20): Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans, or ASU 2018-14. The amendments in ASU 2018-14 eliminate, add, and modify certain disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The amendments are effective for our annual reporting periods beginning after December 15, 2020, with early adoption permitted. The guidance is to be applied on a retrospective basis to all periods presented. We are currently evaluating the effects the adoption of ASU 2018-14 will have on our disclosures.

-11-



In August 2018, the FASB issued Accounting Standards Update No. 2018-12, Financial Services—Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts, or ASU 2018-12. The amendments in ASU 2018-12 make changes to a variety of areas to simplify or improve the existing recognition, measurement, presentation and disclosure requirements for long-duration contracts issued by an insurance entity. The amendments require insurers to annually review the assumptions they make about their policyholders and update the liabilities for future policy benefits if the assumptions change. The amendments also simplify the amortization of deferred contract acquisition costs and add new disclosure requirements about the assumptions insurers use to measure their liabilities and how they may affect future cash flows. The amendments in ASU 2018-12 will be effective for our interim and annual reporting periods beginning after December 15, 2021. The amendments related to the liability for future policy benefits for traditional and limited-payment contracts and deferred acquisition costs are to be applied to contracts in force as of the beginning of the earliest period presented, with an option to apply such amendments retrospectively with a cumulative-effect adjustment to the opening balance of retained earnings as of the earliest period presented. The amendments for market risk benefits are to be applied retrospectively. We are currently evaluating the effects the adoption of ASU 2018-12 will have on our consolidated financial position, results of operations, cash flows, and related disclosures.
There were no other new accounting pronouncements that were issued or became effective since the issuance of our 2019 Annual Report on Form 10-K that had, or are expected to have, a material impact on our consolidated financial position, results of operations or cash flows.
3.
Business Acquisition
Beacon Health Options, Inc.
On February 28, 2020, we completed our acquisition of Beacon Health Options, Inc., or Beacon, the largest independently held behavioral health organization in the country. At the time of acquisition, Beacon served more than thirty-four million individuals across all fifty states. This acquisition aligns with our strategy to diversify into health services and deliver both integrated solutions and care delivery models that personalize care for people with complex and chronic conditions.
In accordance with FASB accounting guidance for business combinations, the consideration transferred was allocated to the preliminary fair value of Beacon’s assets acquired and liabilities assumed, including identifiable intangible assets. The excess of the consideration transferred over the preliminary fair value of net assets acquired resulted in preliminary goodwill of $1,070 at June 30, 2020, all of which was allocated to our Other segment. Preliminary goodwill recognized from the acquisition of Beacon primarily relates to the future economic benefits arising from the assets acquired and is consistent with our stated intentions and strategy. As of June 30, 2020, the initial accounting for the acquisition has not been finalized. Any additional payments or receipts of cash resulting from contractual purchase price adjustments or any subsequent adjustments made to the assets acquired or liabilities assumed during the measurement period will continue to be recorded as an adjustment to goodwill.
The preliminary fair value of the net assets acquired from Beacon includes $752 of other intangible assets at June 30, 2020, which primarily consist of finite-lived customer relationships with amortization periods ranging from 9 to 21 years. The results of operations of Beacon are included in our consolidated financial statements within our Other segment for the period following February 28, 2020. The pro forma effects of this acquisition for prior periods were not material to our consolidated results of operations.
4.
Investments
Fixed Maturity Securities
We evaluate our available-for-sale fixed maturity securities for declines based on qualitative and quantitative factors. The effects of the COVID-19 global health pandemic, or COVID-19, and other market related changes have impacted our fixed maturity securities. We have established an allowance for credit loss and recorded credit loss expense as a reflection of our expected impairment losses. We continue to review our investment portfolios under our impairment review policy. Given the inherent uncertainty of changes in market conditions and the significant judgments involved, there is a continuing risk that declines in fair value may occur and additional material impairment losses on investments may be recorded in future periods.

-12-



Our fixed maturity securities were in a net unrealized gain position of $713 and $673 at June 30, 2020 and December 31, 2019, respectively.
A summary of current and long-term fixed maturity securities, available-for-sale, at June 30, 2020 and December 31, 2019 is as follows:
 
Cost or
Amortized
Cost
 
 
 
 
 
 
 
 
 
Non-Credit
Component of
Impairment Recognized in
Accumulated
Other
Comprehensive
Loss
 
 
Gross
Unrealized
Gains
 
Gross Unrealized Losses
 
Allowance For Credit Losses
 
Estimated
Fair Value
 
 
 
 
Less than
12 Months
 
12 Months
or Greater
 
 
 
June 30, 2020
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed maturity securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
United States Government securities
$
1,250

 
$
17

 
$
(1
)
 
$

 
$

 
$
1,266

 
$

Government sponsored securities
96

 
7

 
(1
)
 

 

 
102

 

Foreign government securities
288

 
7

 
(15
)
 

 
(1
)
 
279

 

States, municipalities and political subdivisions
4,840

 
315

 
(5
)
 

 

 
5,150

 

Corporate securities
9,855

 
469

 
(125
)
 
(28
)
 
(23
)
 
10,148

 
(32
)
Residential mortgage-backed securities
3,696

 
137

 
(26
)
 
(11
)
 

 
3,796

 

Commercial mortgage-backed securities
80

 
2

 
(2
)
 
(4
)
 

 
76

 

Other securities
1,744

 
20

 
(34
)
 
(9
)
 

 
1,721

 

Total fixed maturity securities
$
21,849

 
$
974

 
$
(209
)
 
$
(52
)
 
$
(24
)
 
$
22,538

 
$
(32
)
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed maturity securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
United States Government securities
$
524

 
$
4

 
$
(3
)
 
$

 
$

 
$
525

 
$

Government sponsored securities
136

 
5

 

 

 

 
141

 

States, municipalities and political subdivisions
4,592

 
262

 
(3
)
 

 

 
4,851

 

Corporate securities
8,870

 
339

 
(9
)
 
(15
)
 

 
9,185

 
(3
)
Residential mortgage-backed securities
3,654

 
87

 
(6
)
 
(3
)
 

 
3,732

 

Commercial mortgage-backed securities
84